The global IV and Oral Iron Drugs market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for IV and Oral Iron Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of IV and Oral Iron Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for IV and Oral Iron Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the IV and Oral Iron Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global IV and Oral Iron Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for IV and Oral Iron Drugs revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of IV and Oral Iron Drugs Market Report

Report Metric	Details
Report Name	IV and Oral Iron Drugs Market
CAGR	5%
Segment by Type	Oral Iron Drug IVIron Drugs
Segment by Application	Nephrology OBGYN Surgeries Gastroenterology Oncology Heart failure (HF)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of IV and Oral Iron Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IV and Oral Iron Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, IV and Oral Iron Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the IV and Oral Iron Drugs Market report?

Ans: The main players in the IV and Oral Iron Drugs Market are Daiichi Sankyo Company, Vifor Pharma, Akebia Therapeutics, Allergan, AMAG Pharmaceuticals, AOP Orphan Pharmaceuticals, Pharmacosmos, Sanofi, Shield Therapeutics, AZAD Pharma, Cirondrugs, MEDICE, Pfizer, Salveo Lifecare, Sunny Pharmaceutical

What are the Application segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Applications covered in the IV and Oral Iron Drugs Market report are Nephrology, OBGYN, Surgeries, Gastroenterology, Oncology, Heart failure (HF)

What are the Type segmentation covered in the IV and Oral Iron Drugs Market report?

Ans: The Types covered in the IV and Oral Iron Drugs Market report are Oral Iron Drug, IVIron Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Oral Iron Drug

1.2.3 IVIron Drugs

1.3 Market by Application

1.3.1 Global IV and Oral Iron Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Nephrology

1.3.3 OBGYN

1.3.4 Surgeries

1.3.5 Gastroenterology

1.3.6 Oncology

1.3.7 Heart failure (HF)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global IV and Oral Iron Drugs Market Perspective (2019-2030)

2.2 Global IV and Oral Iron Drugs Growth Trends by Region

2.2.1 IV and Oral Iron Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 IV and Oral Iron Drugs Historic Market Size by Region (2019-2024)

2.2.3 IV and Oral Iron Drugs Forecasted Market Size by Region (2025-2030)

2.3 IV and Oral Iron Drugs Market Dynamics

2.3.1 IV and Oral Iron Drugs Industry Trends

2.3.2 IV and Oral Iron Drugs Market Drivers

2.3.3 IV and Oral Iron Drugs Market Challenges

2.3.4 IV and Oral Iron Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue IV and Oral Iron Drugs by Players

3.1.1 Global IV and Oral Iron Drugs Revenue by Players (2019-2024)

3.1.2 Global IV and Oral Iron Drugs Revenue Market Share by Players (2019-2024)

3.2 Global IV and Oral Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of IV and Oral Iron Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global IV and Oral Iron Drugs Market Concentration Ratio

3.4.1 Global IV and Oral Iron Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by IV and Oral Iron Drugs Revenue in 2023

3.5 Global Key Players of IV and Oral Iron Drugs Head office and Area Served

3.6 Global Key Players of IV and Oral Iron Drugs, Product and Application

3.7 Global Key Players of IV and Oral Iron Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 IV and Oral Iron Drugs Breakdown Data by Type

4.1 Global IV and Oral Iron Drugs Historic Market Size by Type (2019-2024)

4.2 Global IV and Oral Iron Drugs Forecasted Market Size by Type (2025-2030)

5 IV and Oral Iron Drugs Breakdown Data by Application

5.1 Global IV and Oral Iron Drugs Historic Market Size by Application (2019-2024)

5.2 Global IV and Oral Iron Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America IV and Oral Iron Drugs Market Size (2019-2030)

6.2 North America IV and Oral Iron Drugs Market Size by Type

6.2.1 North America IV and Oral Iron Drugs Market Size by Type (2019-2024)

6.2.2 North America IV and Oral Iron Drugs Market Size by Type (2025-2030)

6.2.3 North America IV and Oral Iron Drugs Market Share by Type (2019-2030)

6.3 North America IV and Oral Iron Drugs Market Size by Application

6.3.1 North America IV and Oral Iron Drugs Market Size by Application (2019-2024)

6.3.2 North America IV and Oral Iron Drugs Market Size by Application (2025-2030)

6.3.3 North America IV and Oral Iron Drugs Market Share by Application (2019-2030)

6.4 North America IV and Oral Iron Drugs Market Size by Country

6.4.1 North America IV and Oral Iron Drugs Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America IV and Oral Iron Drugs Market Size by Country (2019-2024)

6.4.3 North America IV and Oral Iron Drugs Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe IV and Oral Iron Drugs Market Size (2019-2030)

7.2 Europe IV and Oral Iron Drugs Market Size by Type

7.2.1 Europe IV and Oral Iron Drugs Market Size by Type (2019-2024)

7.2.2 Europe IV and Oral Iron Drugs Market Size by Type (2025-2030)

7.2.3 Europe IV and Oral Iron Drugs Market Share by Type (2019-2030)

7.3 Europe IV and Oral Iron Drugs Market Size by Application

7.3.1 Europe IV and Oral Iron Drugs Market Size by Application (2019-2024)

7.3.2 Europe IV and Oral Iron Drugs Market Size by Application (2025-2030)

7.3.3 Europe IV and Oral Iron Drugs Market Share by Application (2019-2030)

7.4 Europe IV and Oral Iron Drugs Market Size by Country

7.4.1 Europe IV and Oral Iron Drugs Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe IV and Oral Iron Drugs Market Size by Country (2019-2024)

7.4.3 Europe IV and Oral Iron Drugs Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China IV and Oral Iron Drugs Market Size (2019-2030)

8.2 China IV and Oral Iron Drugs Market Size by Type

8.2.1 China IV and Oral Iron Drugs Market Size by Type (2019-2024)

8.2.2 China IV and Oral Iron Drugs Market Size by Type (2025-2030)

8.2.3 China IV and Oral Iron Drugs Market Share by Type (2019-2030)

8.3 China IV and Oral Iron Drugs Market Size by Application

8.3.1 China IV and Oral Iron Drugs Market Size by Application (2019-2024)

8.3.2 China IV and Oral Iron Drugs Market Size by Application (2025-2030)

8.3.3 China IV and Oral Iron Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia IV and Oral Iron Drugs Market Size (2019-2030)

9.2 Asia IV and Oral Iron Drugs Market Size by Type

9.2.1 Asia IV and Oral Iron Drugs Market Size by Type (2019-2024)

9.2.2 Asia IV and Oral Iron Drugs Market Size by Type (2025-2030)

9.2.3 Asia IV and Oral Iron Drugs Market Share by Type (2019-2030)

9.3 Asia IV and Oral Iron Drugs Market Size by Application

9.3.1 Asia IV and Oral Iron Drugs Market Size by Application (2019-2024)

9.3.2 Asia IV and Oral Iron Drugs Market Size by Application (2025-2030)

9.3.3 Asia IV and Oral Iron Drugs Market Share by Application (2019-2030)

9.4 Asia IV and Oral Iron Drugs Market Size by Region

9.4.1 Asia IV and Oral Iron Drugs Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia IV and Oral Iron Drugs Market Size by Region (2019-2024)

9.4.3 Asia IV and Oral Iron Drugs Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Type

10.2.1 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Application

10.3.1 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country

10.4.1 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Daiichi Sankyo Company

11.1.1 Daiichi Sankyo Company Company Details

11.1.2 Daiichi Sankyo Company Business Overview

11.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Introduction

11.1.4 Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.1.5 Daiichi Sankyo Company Recent Developments

11.2 Vifor Pharma

11.2.1 Vifor Pharma Company Details

11.2.2 Vifor Pharma Business Overview

11.2.3 Vifor Pharma IV and Oral Iron Drugs Introduction

11.2.4 Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.2.5 Vifor Pharma Recent Developments

11.3 Akebia Therapeutics

11.3.1 Akebia Therapeutics Company Details

11.3.2 Akebia Therapeutics Business Overview

11.3.3 Akebia Therapeutics IV and Oral Iron Drugs Introduction

11.3.4 Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.3.5 Akebia Therapeutics Recent Developments

11.4 Allergan

11.4.1 Allergan Company Details

11.4.2 Allergan Business Overview

11.4.3 Allergan IV and Oral Iron Drugs Introduction

11.4.4 Allergan Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.4.5 Allergan Recent Developments

11.5 AMAG Pharmaceuticals

11.5.1 AMAG Pharmaceuticals Company Details

11.5.2 AMAG Pharmaceuticals Business Overview

11.5.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Introduction

11.5.4 AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.5.5 AMAG Pharmaceuticals Recent Developments

11.6 AOP Orphan Pharmaceuticals

11.6.1 AOP Orphan Pharmaceuticals Company Details

11.6.2 AOP Orphan Pharmaceuticals Business Overview

11.6.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Introduction

11.6.4 AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.6.5 AOP Orphan Pharmaceuticals Recent Developments

11.7 Pharmacosmos

11.7.1 Pharmacosmos Company Details

11.7.2 Pharmacosmos Business Overview

11.7.3 Pharmacosmos IV and Oral Iron Drugs Introduction

11.7.4 Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.7.5 Pharmacosmos Recent Developments

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi IV and Oral Iron Drugs Introduction

11.8.4 Sanofi Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.8.5 Sanofi Recent Developments

11.9 Shield Therapeutics

11.9.1 Shield Therapeutics Company Details

11.9.2 Shield Therapeutics Business Overview

11.9.3 Shield Therapeutics IV and Oral Iron Drugs Introduction

11.9.4 Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.9.5 Shield Therapeutics Recent Developments

11.10 AZAD Pharma

11.10.1 AZAD Pharma Company Details

11.10.2 AZAD Pharma Business Overview

11.10.3 AZAD Pharma IV and Oral Iron Drugs Introduction

11.10.4 AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.10.5 AZAD Pharma Recent Developments

11.11 Cirondrugs

11.11.1 Cirondrugs Company Details

11.11.2 Cirondrugs Business Overview

11.11.3 Cirondrugs IV and Oral Iron Drugs Introduction

11.11.4 Cirondrugs Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.11.5 Cirondrugs Recent Developments

11.12 MEDICE

11.12.1 MEDICE Company Details

11.12.2 MEDICE Business Overview

11.12.3 MEDICE IV and Oral Iron Drugs Introduction

11.12.4 MEDICE Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.12.5 MEDICE Recent Developments

11.13 Pfizer

11.13.1 Pfizer Company Details

11.13.2 Pfizer Business Overview

11.13.3 Pfizer IV and Oral Iron Drugs Introduction

11.13.4 Pfizer Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.13.5 Pfizer Recent Developments

11.14 Salveo Lifecare

11.14.1 Salveo Lifecare Company Details

11.14.2 Salveo Lifecare Business Overview

11.14.3 Salveo Lifecare IV and Oral Iron Drugs Introduction

11.14.4 Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.14.5 Salveo Lifecare Recent Developments

11.15 Sunny Pharmaceutical

11.15.1 Sunny Pharmaceutical Company Details

11.15.2 Sunny Pharmaceutical Business Overview

11.15.3 Sunny Pharmaceutical IV and Oral Iron Drugs Introduction

11.15.4 Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2019-2024)

11.15.5 Sunny Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Daiichi Sankyo Company

AOP Orphan Pharmaceuticals

List of Tables

Table 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Oral Iron Drug

Table 3. Key Players of IVIron Drugs

Table 4. Global IV and Oral Iron Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global IV and Oral Iron Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global IV and Oral Iron Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global IV and Oral Iron Drugs Market Share by Region (2019-2024)

Table 8. Global IV and Oral Iron Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global IV and Oral Iron Drugs Market Share by Region (2025-2030)

Table 10. IV and Oral Iron Drugs Market Trends

Table 11. IV and Oral Iron Drugs Market Drivers

Table 12. IV and Oral Iron Drugs Market Challenges

Table 13. IV and Oral Iron Drugs Market Restraints

Table 14. Global IV and Oral Iron Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global IV and Oral Iron Drugs Revenue Share by Players (2019-2024)

Table 16. Global Top IV and Oral Iron Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2023)

Table 17. Global IV and Oral Iron Drugs Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by IV and Oral Iron Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of IV and Oral Iron Drugs, Headquarters and Area Served

Table 20. Global Key Players of IV and Oral Iron Drugs, Product and Application

Table 21. Global Key Players of IV and Oral Iron Drugs, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global IV and Oral Iron Drugs Revenue Market Share by Type (2019-2024)

Table 25. Global IV and Oral Iron Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global IV and Oral Iron Drugs Revenue Market Share by Type (2025-2030)

Table 27. Global IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global IV and Oral Iron Drugs Revenue Share by Application (2019-2024)

Table 29. Global IV and Oral Iron Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global IV and Oral Iron Drugs Revenue Share by Application (2025-2030)

Table 31. North America IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America IV and Oral Iron Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America IV and Oral Iron Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America IV and Oral Iron Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe IV and Oral Iron Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe IV and Oral Iron Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe IV and Oral Iron Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 45. China IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 46. China IV and Oral Iron Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 47. China IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 48. China IV and Oral Iron Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia IV and Oral Iron Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia IV and Oral Iron Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia IV and Oral Iron Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia IV and Oral Iron Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia IV and Oral Iron Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America IV and Oral Iron Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 63. Daiichi Sankyo Company Company Details

Table 64. Daiichi Sankyo Company Business Overview

Table 65. Daiichi Sankyo Company IV and Oral Iron Drugs Product

Table 66. Daiichi Sankyo Company Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 67. Daiichi Sankyo Company Recent Developments

Table 68. Vifor Pharma Company Details

Table 69. Vifor Pharma Business Overview

Table 70. Vifor Pharma IV and Oral Iron Drugs Product

Table 71. Vifor Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 72. Vifor Pharma Recent Developments

Table 73. Akebia Therapeutics Company Details

Table 74. Akebia Therapeutics Business Overview

Table 75. Akebia Therapeutics IV and Oral Iron Drugs Product

Table 76. Akebia Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 77. Akebia Therapeutics Recent Developments

Table 78. Allergan Company Details

Table 79. Allergan Business Overview

Table 80. Allergan IV and Oral Iron Drugs Product

Table 81. Allergan Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 82. Allergan Recent Developments

Table 83. AMAG Pharmaceuticals Company Details

Table 84. AMAG Pharmaceuticals Business Overview

Table 85. AMAG Pharmaceuticals IV and Oral Iron Drugs Product

Table 86. AMAG Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 87. AMAG Pharmaceuticals Recent Developments

Table 88. AOP Orphan Pharmaceuticals Company Details

Table 89. AOP Orphan Pharmaceuticals Business Overview

Table 90. AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Product

Table 91. AOP Orphan Pharmaceuticals Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 92. AOP Orphan Pharmaceuticals Recent Developments

Table 93. Pharmacosmos Company Details

Table 94. Pharmacosmos Business Overview

Table 95. Pharmacosmos IV and Oral Iron Drugs Product

Table 96. Pharmacosmos Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 97. Pharmacosmos Recent Developments

Table 98. Sanofi Company Details

Table 99. Sanofi Business Overview

Table 100. Sanofi IV and Oral Iron Drugs Product

Table 101. Sanofi Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 102. Sanofi Recent Developments

Table 103. Shield Therapeutics Company Details

Table 104. Shield Therapeutics Business Overview

Table 105. Shield Therapeutics IV and Oral Iron Drugs Product

Table 106. Shield Therapeutics Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 107. Shield Therapeutics Recent Developments

Table 108. AZAD Pharma Company Details

Table 109. AZAD Pharma Business Overview

Table 110. AZAD Pharma IV and Oral Iron Drugs Product

Table 111. AZAD Pharma Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 112. AZAD Pharma Recent Developments

Table 113. Cirondrugs Company Details

Table 114. Cirondrugs Business Overview

Table 115. Cirondrugs IV and Oral Iron Drugs Product

Table 116. Cirondrugs Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 117. Cirondrugs Recent Developments

Table 118. MEDICE Company Details

Table 119. MEDICE Business Overview

Table 120. MEDICE IV and Oral Iron Drugs Product

Table 121. MEDICE Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 122. MEDICE Recent Developments

Table 123. Pfizer Company Details

Table 124. Pfizer Business Overview

Table 125. Pfizer IV and Oral Iron Drugs Product

Table 126. Pfizer Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 127. Pfizer Recent Developments

Table 128. Salveo Lifecare Company Details

Table 129. Salveo Lifecare Business Overview

Table 130. Salveo Lifecare IV and Oral Iron Drugs Product

Table 131. Salveo Lifecare Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 132. Salveo Lifecare Recent Developments

Table 133. Sunny Pharmaceutical Company Details

Table 134. Sunny Pharmaceutical Business Overview

Table 135. Sunny Pharmaceutical IV and Oral Iron Drugs Product

Table 136. Sunny Pharmaceutical Revenue in IV and Oral Iron Drugs Business (2019-2024) & (US$ Million)

Table 137. Sunny Pharmaceutical Recent Developments

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global IV and Oral Iron Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global IV and Oral Iron Drugs Market Share by Type: 2023 VS 2030

Figure 3. Oral Iron Drug Features

Figure 4. IVIron Drugs Features

Figure 5. Global IV and Oral Iron Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global IV and Oral Iron Drugs Market Share by Application: 2023 VS 2030

Figure 7. Nephrology Case Studies

Figure 8. OBGYN Case Studies

Figure 9. Surgeries Case Studies

Figure 10. Gastroenterology Case Studies

Figure 11. Oncology Case Studies

Figure 12. Heart failure (HF) Case Studies

Figure 13. IV and Oral Iron Drugs Report Years Considered

Figure 14. Global IV and Oral Iron Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global IV and Oral Iron Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global IV and Oral Iron Drugs Market Share by Region: 2023 VS 2030

Figure 17. Global IV and Oral Iron Drugs Market Share by Players in 2023

Figure 18. Global Top IV and Oral Iron Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV and Oral Iron Drugs as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by IV and Oral Iron Drugs Revenue in 2023

Figure 20. North America IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America IV and Oral Iron Drugs Market Share by Type (2019-2030)

Figure 22. North America IV and Oral Iron Drugs Market Share by Application (2019-2030)

Figure 23. North America IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 24. United States IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe IV and Oral Iron Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe IV and Oral Iron Drugs Market Share by Type (2019-2030)

Figure 28. Europe IV and Oral Iron Drugs Market Share by Application (2019-2030)

Figure 29. Europe IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 30. Germany IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China IV and Oral Iron Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China IV and Oral Iron Drugs Market Share by Type (2019-2030)

Figure 38. China IV and Oral Iron Drugs Market Share by Application (2019-2030)

Figure 39. Asia IV and Oral Iron Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia IV and Oral Iron Drugs Market Share by Type (2019-2030)

Figure 41. Asia IV and Oral Iron Drugs Market Share by Application (2019-2030)

Figure 42. Asia IV and Oral Iron Drugs Market Share by Region (2019-2030)

Figure 43. Japan IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America IV and Oral Iron Drugs Market Share by Country (2019-2030)

Figure 53. Brazil IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries IV and Oral Iron Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Daiichi Sankyo Company Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 60. Vifor Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 61. Akebia Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 62. Allergan Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 64. AOP Orphan Pharmaceuticals Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 65. Pharmacosmos Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 66. Sanofi Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 67. Shield Therapeutics Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 68. AZAD Pharma Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 69. Cirondrugs Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 70. MEDICE Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 71. Pfizer Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 72. Salveo Lifecare Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 73. Sunny Pharmaceutical Revenue Growth Rate in IV and Oral Iron Drugs Business (2019-2024)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-3J10777

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteral Medicine Straw Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31N10509

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Bupropion Hydrochloride Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4W9519

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Calcium Dobesilate Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24P10026

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global IV and Oral Iron Drugs Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-34F7094

Global IV and Oral Iron Drugs Market Insights, Forecast to 2030

FEATURED COMPANIES

IV and Oral Iron Drugs Market Size

IV and Oral Iron Drugs Market

Scope of IV and Oral Iron Drugs Market Report

Chapter Outline

FAQ for this report

Who are the main players in the IV and Oral Iron Drugs Market report?

What are the Application segmentation covered in the IV and Oral Iron Drugs Market report?

What are the Type segmentation covered in the IV and Oral Iron Drugs Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User